Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
25/04/2025 16:01
April 25 (Reuters) - China Regenerative Medicine International Ltd 8158.HK: YAN SHIBIN WILL BE APPOINTED AS CFO WONG PO TIN WILL CEASE TO BE CFO Further company coverage: 8158.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital